DEM BioPharma, Inc. (DEM Bio), a biopharmaceutical company dedicated to discovering novel targets for solid tumors and ...

Explore the landscape of Nigerian politicking in 2026 as parties realign and INEC prepares for the 2027 general elections.

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer ...

HMBD-501 is a HER3-targeted ADC with a differentiated mechanism of action, engineered by Hummingbird Bioscience for optimal safety and efficacy ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Agree Realty's (ADC) investment volume for Q4 2025 totaled more than $347M at a 7.1% weighted-average cap rate, it said on ...

CR-001 IND cleared by U.S. FDA; Phase 1/2 ASCEND global clinical trial to evaluate CR-001 in first-line and previously ...

ArriVent Biopharma, a company that secures rights to drugs from emerging markets to develop them for Western markets, is adding to its pipeline with a Phase 1-ready drug candidate from China that has ...

An announcement from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H ( ($HK:6990) ) is now available. Sichuan Kelun-Biotech announced ...

As 2027 approaches, Kaduna voters appear less interested in slogans and are more attentive to competence, security, and economic relief. If ADC can translate its growing coalition into a coherent ...

An ADC chieftain, Kelly Agaba, has explained what the chances of the party will be if Peter Obi decides not to work with ...

Watching theatre is a joy of mine that Cambridge has satiated, having spent several memorable evenings during Michaelmas term ...